viral
spread
consid
promis
target
antivir
therapeut
associ
mechan
remain
unclear
gallid
alpha
herpesviru
iltv
previous
identifi
protooncogen
tyrosineprotein
kinas
src
src
crucial
host
determin
iltv
infect
present
studi
reveal
acceler
spread
iltv
upon
src
inhibit
phenomenon
independ
either
viral
replic
prolifer
infect
cell
could
compromis
neutral
antibodi
neither
extracellular
vesicl
direct
cytosoltocytosol
connect
adjac
cell
contribut
enhanc
spread
iltv
upon
src
inhibit
genomewid
transcript
profil
analys
combin
function
valid
identifi
fatti
acid
metabol
essenti
molecular
event
modul
intercellular
spread
subsequ
cytopath
effect
iltv
src
overal
data
suggest
src
control
celltocel
spread
iltv
cellular
fatti
acid
metabolismdepend
manner
determin
viru
cytopath
effect
spread
infecti
virus
host
cell
import
viral
replic
virul
pathogenesi
flint
et
al
two
rout
exist
viral
spread
cellfre
spread
involv
infect
new
cell
extracellular
virion
vesicl
contain
infecti
materi
releas
infect
cell
celltocel
spread
involv
viral
particl
transmiss
cell
via
celltocel
contact
direct
connect
moth
et
al
sattentau
cellfre
spread
well
establish
import
distant
viral
dissemin
transmiss
host
tissuetotissu
spread
within
host
bodi
blood
lymph
cerebrospin
fluid
distant
spread
virus
must
releas
host
cell
howev
releas
extracellular
environ
virus
expos
sever
barrier
block
subsequ
cellfre
spread
includ
biophys
barrier
mucou
membran
cell
intrins
barrier
associ
host
immunosurveil
kinet
barrier
due
process
random
fluidphas
diffus
attach
viru
host
cell
membran
penetr
virus
bound
host
cell
achiev
success
distant
dissemin
barrier
must
overcom
virus
consid
disadvantag
cellfre
spread
mani
virus
evolv
exploit
celltocel
spread
altern
strategi
overcom
barrier
celltocel
spread
proven
import
infect
mani
clinic
import
virus
herpesvirus
poxvirus
measl
viru
hepat
c
viru
human
immunodefici
viru
type
rabi
viru
christian
et
al
ritzenthal
sattentau
sattentau
wheeler
alphaherpesvirus
main
rout
spread
tissu
celltocel
spread
primari
infect
mucocutan
tissu
establish
latent
infect
sensori
neuron
reactiv
latenc
viru
spread
intercellularli
mucocutan
tissu
sensori
neuron
abaitua
et
al
arvin
et
al
celltocel
spread
inhibitori
activ
infectionelicit
neutral
antibodi
found
extrem
limit
herp
simplex
viru
subject
http
receiv
may
receiv
revis
form
juli
accept
august
criscuolo
et
al
avian
gallid
alpha
herpesviru
iltv
belong
famili
herpesvirida
subfamili
alphaherpesvirina
continu
caus
great
econom
loss
poultri
industri
ou
giambron
despit
success
protect
vaccin
coppo
et
al
similar
alphaherpesvirus
iltv
establish
latenc
nervou
system
acut
infect
upper
respiratori
tract
clear
host
current
avail
therapeut
treatment
therefor
reactiv
iltv
latent
infect
frequent
occur
host
stress
host
immun
compromis
hugh
et
al
hugh
et
al
ou
giambron
thu
elucid
mechan
respons
celltocel
spread
facilit
develop
novel
therapeut
strategi
control
viru
reactiv
design
effect
vaccin
combat
iltv
protooncogen
tyrosineprotein
kinas
src
src
origin
isol
chicken
sarcoma
thought
contribut
oncogenesi
vogt
src
shown
import
factor
wide
rang
biolog
process
cell
prolifer
adhes
divis
death
angiogenesi
organ
cytoskeleton
src
also
report
involv
infect
wide
rang
virus
includ
polyoma
viru
dengu
coronavirus
influenza
viru
herpesviru
bolen
et
al
burkard
et
al
cheshenko
et
al
gaur
et
al
krishnan
et
al
kumar
et
al
mccarthi
et
al
suggest
src
may
new
potenti
target
antivir
therapeut
agent
may
potenti
repurpos
exist
fdaapprov
src
inhibitor
howev
clinic
applic
antivir
srctarget
agent
report
may
least
partial
due
complic
role
src
regul
multipl
biolog
process
involv
biolog
effect
src
complex
sometim
controversi
exampl
studi
suggest
src
essenti
pdgfinduc
dna
synthesi
baron
courtneidg
twamleystein
et
al
howev
studi
pdgfinduc
dna
synthesi
indic
src
absolut
requir
even
play
opposit
role
demali
kazlauska
rosenkranz
et
al
addit
src
consid
surviv
factor
death
factor
depend
specif
cellular
condit
fan
et
al
fan
et
al
fan
et
al
iqbal
hossain
et
al
previou
studi
identifi
src
key
host
determin
iltv
infect
li
et
al
found
activ
host
src
upon
iltv
infect
rais
threshold
host
cell
iltv
infectioninduc
cell
death
thu
maintain
surviv
infect
cell
ensur
high
level
viral
replic
howev
therapi
target
src
repress
viral
replic
also
exacerb
patholog
effect
iltv
even
increas
likelihood
death
host
underli
molecular
mechan
suffici
investig
develop
srcbase
therapeut
limit
viral
replic
requir
host
cellular
metabol
similar
exist
virusspecif
metabol
requir
differ
virus
identifi
mani
virus
shown
induc
fatti
acid
synthesi
host
cell
provid
stabl
carbon
sourc
suffici
energi
viral
replic
viral
spread
even
prolong
surviv
infect
cell
munger
sanchez
lagunoff
sanchez
et
al
although
mechan
remain
unclear
iltv
util
host
fatti
acid
metabol
found
import
latent
lytic
infect
human
gamma
herpesviru
kaposi
sarcomaassoci
herpesviru
kshv
surviv
infect
cell
delgado
et
al
sanchez
et
al
thu
better
understand
involv
fatti
acid
metabol
viral
infect
may
lead
develop
novel
therapeut
approach
target
specif
cellular
metabol
process
present
studi
observ
acceler
celltocel
spread
iltv
src
inhibit
cellular
fatti
acid
metabolismdepend
manner
determin
cytopath
effect
cpe
iltv
given
import
celltocel
spread
iltv
infect
evidenc
effici
protect
iltv
infect
provid
host
cellmedi
immun
rather
humour
immun
coppo
et
al
mechan
reveal
may
valuabl
futur
develop
ration
antiiltv
vaccin
virul
strain
genbank
access
store
harbin
veterinari
research
institut
caa
strain
propag
chemic
immort
leghorn
male
hepatoma
lmh
cell
line
clear
cpe
observ
zhao
et
al
iltvegfp
construct
replac
gene
egfp
code
sequenc
describ
previous
li
et
al
lmh
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
unitsml
penicillin
streptomycin
mm
lglutamin
cell
cultur
incub
co
src
inhibitor
purchas
sellckchemcom
selleck
chemic
llc
houston
tx
acid
tofa
alloster
inhibitor
acetyl
coa
carboxylas
synthet
fattyacid
synthas
fasn
inhibitor
purchas
sigma
aldrich
sigma
aldrich
st
loui
mo
given
inhibitor
use
dissolv
dimethyl
sulfoxid
dmso
cell
treat
dmso
volum
use
chemic
control
dil
calcein
purchas
beyotim
biotechnolog
beyotim
biotech
shanghai
china
shortinterf
rna
sirna
pool
specif
recogn
differ
sequenc
src
mrna
control
sirna
specif
target
site
chicken
use
li
et
al
transfect
sirna
conduct
use
nter
nanoparticl
sirna
transfect
system
sigma
aldrich
accord
manufactur
instruct
lmh
cell
infect
iltv
multipl
infect
moi
indic
moi
obtain
accord
number
cell
infect
estim
number
infecti
particl
base
plaqueform
unit
detect
lmh
cell
level
viru
replic
determin
use
plaqu
assay
iltvspecif
qpcr
assay
previous
describ
li
et
al
determin
total
level
viral
replic
cellassoci
virus
virus
releas
supernat
collect
viru
quantif
cell
lyse
via
three
round
freezingthaw
conduct
fac
analys
use
bd
facscan
cellquest
softwar
version
bd
mountain
view
ca
activ
src
assay
use
antibodi
phosphoryl
src
emd
millipor
billerica
usa
follow
secondari
goat
antimous
antibodi
conjug
apc
jackson
laboratori
bar
harbor
mous
igg
use
isotyp
control
abcam
trade
compani
ltd
shanghai
china
proport
iltvinfect
cell
determin
via
detect
egfpposit
cell
use
rabbit
polyclon
antibodi
iltv
glycoprotein
li
et
al
follow
secondari
goat
antirabbit
antibodi
conjug
fitc
jackson
laboratori
background
determin
normal
rabbit
control
serum
nonimmun
rabbit
cell
death
assay
propidium
iodid
pi
stain
live
cell
immunofluoresc
examin
fluoresc
signal
detect
evo
fl
fluoresc
microscop
amg
bothel
wa
cell
nuclei
highlight
hoechst
sigma
aldrich
iltvegfpinfect
cell
uninfect
cell
cocultur
ratio
absenc
presenc
src
inhibitor
dish
dish
place
heat
chamber
environment
control
miniincub
maintain
co
imag
captur
ultraview
vox
confoc
imag
system
perkinelm
waltham
nikon
eclips
ti
stand
nikon
instrument
melvil
ny
len
control
voloc
softwar
perkinelm
extracellular
vesicl
includ
exosom
microvesicl
prepar
examin
perform
accord
previou
descript
jung
mun
lmh
cell
cultur
near
confluenc
cm
dish
cell
mock
infect
infect
moi
serumfre
dmem
h
cell
wash
pb
cultur
extracellular
vesiclefre
full
dmem
medium
absenc
present
medium
harvest
hpi
extracellular
vesicl
purifi
differenti
centrifug
min
min
min
use
beckman
fix
angl
rotor
ultracentrifug
min
use
beckman
swing
bucket
rotor
extracellular
vesicl
pellet
gener
resuspend
serumfre
dmem
fix
dri
sampl
coat
goldpalladium
alloy
sputter
coat
examin
hitachi
transmiss
electron
microscop
hitachi
high
technolog
shanghai
china
imag
taken
use
amt
ccd
camera
advanc
microscopi
techniqu
woburn
western
blot
perform
reduc
denatur
condit
accord
previous
describ
procedur
li
et
al
briefli
cell
wash
icecold
pb
solubl
protein
extract
cell
lysi
buffer
mm
trishcl
ph
mm
nacl
phosphatas
proteas
inhibitor
cocktail
tablet
abcam
accord
manufactur
protocol
protein
concentr
determin
use
biorad
bradford
assay
biorad
hercul
ca
bsa
standard
sigma
aldrich
equal
amount
protein
separ
sdspage
antibodi
src
emd
millipor
actin
sigma
aldrich
use
genomewid
gene
express
profil
lmh
cell
perform
use
rna
deep
sequenc
annoroad
gene
technolog
co
ltd
beij
china
librari
construct
perform
follow
illumina
san
diego
ca
manufactur
instruct
sampl
sequenc
illumina
hiseq
instrument
rna
isol
lmh
cell
use
rneasi
plu
mini
kit
qiagen
hilden
germani
accord
manufactur
protocol
rtqpcr
perform
use
sybr
kit
takara
bio
inc
tokyo
japan
describ
previous
cong
et
al
primer
sequenc
present
tabl
data
calcul
method
result
present
log
fold
chang
rna
sequenc
data
analyz
webbas
tool
galaxi
blankenberg
et
al
pathway
analysi
perform
david
geneenrich
analysi
use
eas
score
modifi
fisher
exact
pvalu
threshold
rna
sequenc
raw
data
upload
ncbi
access
number
spss
softwar
packag
spss
window
version
spss
inc
chicago
il
usa
use
statist
analys
data
obtain
sever
experi
report
mean
standard
deviat
sd
signific
differ
two
group
determin
student
ttest
oneway
twoway
analysi
varianc
bonferroni
correct
employ
multigroup
comparison
analys
probabl
p
valu
consid
statist
signific
strain
express
enhanc
green
fluoresc
protein
egfp
exhibit
signific
differ
wild
type
either
viral
replic
cpe
infect
describ
previous
li
et
al
employ
monitor
viral
infect
egfp
strain
investig
effect
src
repress
transmiss
iltv
leghorn
male
hepatoma
lmh
cell
multipl
infect
moi
first
perform
src
deplet
use
pool
sirna
target
differ
sequenc
src
src
deplet
confirm
western
blot
fig
upon
iltv
infect
egfp
signal
observ
approxim
cell
h
post
infect
tabl
list
rtqpcr
primer
wang
et
al
virolog
hpi
met
expect
proport
moi
increas
significantli
src
deplet
proven
detect
egfpposit
cell
via
fluorescenceactiv
cell
sort
fac
fig
similar
conclus
obtain
use
antibodi
specif
target
gi
protein
iltv
assay
fac
fig
suggest
proport
egfpposit
cell
use
reflect
iltv
spread
model
consist
find
ident
result
obtain
cell
repress
src
activ
one
two
wide
use
src
inhibitor
repress
src
transcript
src
phosphoryl
lmh
cell
fig
e
assay
fac
fig
g
find
demonstr
induc
spread
iltv
repress
src
activ
lmh
cell
address
whether
viral
replic
contribut
acceler
iltv
dissemin
src
inhibit
lmh
cell
measur
total
viral
titr
includ
cellassoci
virus
virus
releas
supernat
use
iltvspecif
qpcr
fig
plagu
format
assay
fig
consist
previou
find
src
import
iltv
maintain
high
level
viral
product
li
et
al
final
product
virus
significantli
reduc
src
inhibitor
assay
day
post
infect
dpi
cell
treat
dpi
cell
treat
dmso
infect
cell
dead
correspond
deplet
src
lmh
cell
perform
pool
two
sirna
target
differ
sequenc
src
protein
level
src
assess
immunoblot
actin
use
load
control
b
c
percentag
infect
cell
h
post
infect
upon
deplet
src
quantifi
fac
via
detect
egfpposit
cell
b
use
polyclon
antibodi
glycoprotein
iltv
produc
rabbit
follow
apcconjug
antirabbit
second
antibodi
c
background
determin
normal
rabbit
serum
e
src
inhibit
assay
rtqpcr
fac
use
antibodi
specif
recogn
phosphoryl
src
follow
apcconjug
antirabbit
secondari
antibodi
e
background
determin
normal
rabbit
igg
control
f
g
percentag
infect
cell
h
post
infect
upon
inhibit
src
quantifi
fac
via
detect
egfpposit
cell
f
use
polyclon
antibodi
glycoprotein
iltv
produc
rabbit
follow
apcconjug
antirabbit
second
antibodi
g
background
determin
normal
rabbit
serum
result
b
c
f
g
present
mean
sd
n
asterisk
indic
statist
differ
p
z
wang
et
al
virolog
time
point
indic
end
fig
b
howev
neither
method
reveal
differ
viral
titr
cell
absenc
presenc
src
inhibitor
within
three
dpi
period
viral
genom
copi
continu
increas
infect
group
exist
virion
even
undetect
dpi
fig
similar
level
viral
replic
within
dpi
demonstr
acceler
viral
spread
src
inhibit
observ
hpi
independ
viral
replic
next
detail
investig
iltv
dissemin
carri
monitor
spread
egfp
use
timelaps
microscopi
iltvegfpinfect
cell
use
donor
cell
uninfect
cell
use
target
cell
cocultur
ratio
absenc
presenc
src
inhibitor
shown
timelaps
microscopi
egfp
signal
appear
hpi
iltvinfect
group
transmiss
egfp
signal
first
occur
cell
treat
src
inhibitor
hpi
rare
observ
cell
absenc
src
inhibit
throughout
observ
period
fig
interestingli
egfp
signal
mainli
spread
infect
cell
adjac
uninfect
cell
rather
uninfect
cell
without
direct
contact
infect
cell
therefor
hypothes
distant
transmiss
extracellular
iltv
particl
extracellular
vesicl
contribut
enhanc
iltv
spread
observ
address
hypothesi
rabbit
polyclon
antibodi
iltv
glycoprotein
produc
lab
li
et
al
util
neutral
antibodi
block
virion
releas
cultur
medium
infect
cell
neutral
extracellular
virion
antibodi
verifi
observ
egfpposit
cell
fig
howev
promot
iltv
spread
src
inhibit
compromis
addit
neutral
antibodi
assay
fac
fig
hypothesi
confirm
fact
neither
amount
infect
extracellular
vesicl
includ
exosom
microvesicl
secret
cultur
medium
affect
src
inhibit
presenc
neutral
antibodi
fig
taken
togeth
find
suggest
src
inhibit
promot
iltv
spread
mainli
celltocel
manner
addit
viral
replic
initi
infect
prolifer
infect
cell
may
also
contribut
enhanc
viral
spread
src
inhibit
experiment
system
given
initi
infect
group
studi
next
address
whether
acceler
iltv
transmiss
src
inhibit
due
prolifer
infect
cell
answer
question
iltvegfp
infect
cell
use
donor
cell
uninfect
cell
label
dil
use
target
cell
cocultur
ratio
absenc
presenc
src
inhibitor
upon
addit
neutral
antibodi
indic
fig
left
panel
src
inhibit
either
inhibitor
significantli
increas
proport
cell
posit
egfp
dil
proport
cell
posit
egfp
neg
dil
fig
right
panel
assay
fac
suggest
prolifer
infect
cell
celltocel
spread
virus
contribut
enhanc
spread
iltv
src
inhibit
system
src
inhibit
like
promot
iltv
spread
via
latter
mechan
sinc
proport
egfpdil
doubleposit
cell
approxim
ninetim
cell
posit
egfp
taken
togeth
find
suggest
src
inhibit
promot
iltv
transmiss
mainli
celltocel
manner
inhibit
src
promot
celltocel
spread
iltv
independ
direct
cytosoltocytosol
connect
alphaherpesvirus
transmit
intercellularli
infect
cell
neighbour
cell
either
pass
cytosoltocytosol
connect
directli
cross
contact
cell
kadiu
gendelman
luca
determin
pathway
src
inhibit
promot
celltocel
spread
iltv
dissemin
calcein
dye
solubl
cytoplasm
freeli
pass
cytosoltocytosol
connect
assay
iltvinfect
uninfect
cell
stain
calcein
use
donor
cell
label
dil
use
target
given
proport
cell
posit
calcein
dil
detect
fac
low
analys
ratio
lower
group
donor
target
cocultur
ratio
presenc
src
inhibitor
dmso
indic
fig
assay
fac
direct
cytosoltocytosol
connect
occur
natur
uninfect
cell
significantli
promot
iltv
infect
fig
howev
connect
affect
src
activ
togeth
low
frequenc
ratio
find
exclud
possibl
involv
direct
cytosoltocytosol
connect
enhanc
intercellular
spread
iltv
src
inhibit
inhibit
src
promot
iltv
celltocel
spread
cellular
fatti
acid
metabolismdepend
manner
elucid
molecular
mechan
underli
acceler
celltocel
spread
iltv
src
inhibit
genomewid
transcript
profil
analysi
conduct
rna
isol
mock
cell
iltvinfect
cell
distinct
src
activ
subject
rna
sequenc
bioinformat
analys
identifi
gene
differenti
express
among
group
base
follow
criteria
pvalu
ii
qvalu
iii
fold
chang
tabl
hierarch
cluster
analysi
use
differenti
express
gene
demonstr
effici
cluster
biolog
replic
group
cell
fig
among
group
genomewid
transcript
profil
uninfect
cell
genomewid
transcript
profil
infect
cell
cluster
separ
total
upregul
gene
downregul
gene
identifi
upon
iltv
infect
absenc
src
inhibit
fig
valid
purpos
transcript
level
randomli
select
gene
examin
use
rtqpcr
assay
rtqpcr
result
correspond
rnaseq
assay
fig
among
gene
significantli
alter
iltv
infect
absenc
src
inhibit
upregul
gene
downregul
gene
halt
treatment
b
replic
iltv
lmh
cell
determin
iltvspecif
qpcr
plaqu
assay
b
respect
result
present
mean
sd
n
asterisk
indic
statist
differ
p
z
wang
et
al
virolog
regul
gene
downregul
gene
attenu
treatment
fig
accordingli
upregul
gene
downregul
gene
commonli
regul
treatment
fig
left
panel
name
gene
uniqu
upregulateddownregul
iltv
infect
among
gene
unaffect
iltv
infect
gene
upregul
gene
downregul
treatment
gene
upregul
gene
downregul
treatment
upon
iltv
infect
fig
upregul
gene
downregul
gene
common
fig
left
panel
name
gene
uniqu
alter
src
inhibitor
consid
differ
transcript
profil
cell
treat
avoid
offtarget
effect
inhibitor
gene
subset
commonli
alter
treatment
iltvinfect
cell
includ
analys
pathway
analysi
use
david
function
annot
pvalu
reveal
pathway
involv
fatti
acid
metabol
process
significantli
enrich
gene
uniqu
downregul
iltv
infect
fig
right
panel
tabl
uncov
pathway
enrich
either
gene
uniqu
alter
src
inhibitor
gene
uniqu
upregul
iltv
infect
david
function
annot
cluster
analysi
enrich
score
use
gene
uniqu
downregul
iltv
infect
identifi
fatti
acid
metabolismrel
biolog
process
cluster
biolog
process
highest
enrich
score
fig
verifi
role
fatti
acid
metabol
acceler
intercellular
spread
iltv
src
inhibit
two
wide
use
chemic
specif
inhibit
fatti
acid
synthesi
name
alloster
inhibitor
acetyl
coa
carboxylas
tofa
synthet
fattyacid
synthas
inhibitor
employ
without
addit
palmit
acid
pal
shown
fig
inhibitor
affect
replic
viral
dna
significantli
repress
virion
product
p
assay
iltvspecif
qpcr
fig
plagu
format
assay
fig
suggest
fatti
acid
metabol
requir
viral
genom
replic
essenti
virion
product
consid
potenti
influenc
effect
tofa
iltv
replic
neutral
antibodi
ad
investig
role
fatti
acid
metabol
promot
viral
spread
cell
death
src
repress
via
fac
fig
e
tofa
compromis
promot
effect
src
inhibit
viral
spread
fig
inhibitori
effect
tofa
virion
product
viral
celltocel
spread
lmh
cell
upon
src
inhibit
rescu
addit
pal
fig
c
enhanc
death
infect
cell
src
inhibit
also
reduc
tofa
fig
e
signific
effect
cell
death
observ
cell
treat
tofa
fig
e
suggest
chemic
cytotox
lmh
cell
thu
data
demonstr
fatti
acid
metabol
essenti
regul
celltocel
spread
cytopathogen
iltv
src
celltocel
spread
intracellular
pathogen
one
mechan
emerg
coevolut
viru
host
import
pathogenesi
viral
infect
also
antimicrobi
therapi
current
antivir
drug
target
latent
infect
alphaherpesviru
avail
lead
outbreak
host
stress
host
immun
system
compromis
establish
latent
infect
sensori
neuron
reactiv
latenc
viru
spread
intercellularli
mucocutan
tissu
sensori
neuron
arvin
et
al
abaitua
et
al
thu
elucid
underli
mechan
modul
celltocel
spread
alphaherpesvirus
may
provid
promis
target
develop
novel
therapeut
strategi
refin
ration
design
effect
vaccin
combat
alphaherpesvirus
despit
extens
research
effort
precis
intercellular
dissemin
mechan
remain
larg
unclear
iltv
share
common
characterist
alphaherpesvirus
includ
resist
host
humour
immun
respons
coppo
et
al
indic
import
intercellular
viru
spread
iltv
infect
previou
studi
identifi
src
key
host
determin
iltv
infect
present
studi
found
src
act
key
orchestr
iltv
host
infect
control
viral
celltocel
transmiss
subsequ
cell
death
cellular
fatti
acid
metabolismdepend
manner
find
provid
new
insight
regard
mechan
host
src
regul
iltv
infect
may
also
help
reveal
mechan
celltocel
spread
alphaherpesvirus
numer
effort
made
elucid
mechan
involv
intercellular
spread
virus
simplest
wide
use
model
celltocel
spread
plaqu
format
cell
cultur
without
addit
neutral
antibodi
reflect
cumul
process
hostviru
interact
includ
viral
bind
penetr
replic
reorgan
celltocel
junction
viral
intercellular
transport
restrict
mechan
use
host
resist
infect
antivir
immun
respons
factor
dingwel
et
al
johnson
et
al
mettenleit
et
al
model
frequent
use
investig
process
celltocel
spread
essenti
viral
host
factor
process
farnsworth
johnson
krummenach
et
al
sourvino
everett
recent
studi
util
advanc
techniqu
equip
visual
viral
infect
live
cell
timelaps
microscopi
reveal
novel
featur
viral
celltocel
spread
previous
unexpect
unrecogn
instanc
mani
virus
observ
spread
z
wang
et
al
virolog
faster
limit
impos
replic
kinet
poxvirus
repuls
superinfect
virion
infect
cell
mediat
viral
protein
speed
viral
spread
fourtim
faster
expect
accord
replic
kinet
doceul
et
al
doceul
et
al
rapid
viral
celltocel
spread
also
observ
hiv
herpesvirus
paracrinedepend
migrat
uninfect
cell
site
infect
abaitua
et
al
igakura
et
al
jolli
sattentau
well
intercellular
spread
via
nanotub
eugenin
et
al
thought
contribut
phenomenon
cytoplasm
connect
promot
spread
virus
herpesvirus
transport
viral
genom
viral
capsid
vesicl
contain
viral
particl
adjac
cell
digel
et
al
fan
et
al
luca
present
studi
suggest
despit
enhanc
iltv
infect
direct
cytosoltocytosol
connect
contribut
promot
intercellular
spread
iltv
src
inhibit
z
wang
et
al
virolog
fig
addit
herpesvirus
travel
infect
cell
neighbour
cell
via
bud
basolater
intercellular
junction
cross
tight
junction
cell
cocchi
et
al
dingwel
et
al
york
johnson
whether
mechan
respons
acceler
spread
iltv
observ
remain
unclear
studi
util
transmiss
electron
microscopi
need
investig
exact
mechan
enhanc
celltocel
spread
iltv
src
inhibit
previou
present
studi
suggest
src
play
complex
role
iltv
infect
one
hand
src
activ
rais
threshold
infect
host
cell
infectioninduc
host
cell
death
prolong
durat
iltv
replic
infect
cell
allow
infiltr
viru
achiev
optim
replic
meanwhil
along
src
activ
iltv
infect
also
tend
acceler
viral
celltocel
spread
unexpectedli
accord
find
present
studi
process
restrict
activ
host
src
trigger
iltv
infect
sum
src
activ
iltv
ensur
ultim
replic
virus
infect
cell
also
limit
viral
dissemin
iltv
activ
host
src
achiev
opposit
function
show
previou
z
wang
et
al
virolog
studi
src
inhibit
repress
iltv
replic
also
reduc
threshold
infect
cell
iltvtrigg
cell
death
patholog
damag
li
et
al
consid
rapid
establish
latent
infect
initi
infect
iltv
opposit
effect
src
activ
iltv
infect
like
reflect
strategi
evolv
coevolut
iltv
host
establish
balanc
pathogenhost
interact
host
metabol
requir
maxim
viral
product
examin
sever
human
herpesvirus
includ
human
cytomegaloviru
hcmv
herp
simplex
viru
kshv
delgado
et
al
munger
et
al
munger
et
al
sanchez
et
al
vastag
et
al
result
suggest
inhibit
specif
cellular
metabol
pathway
elimin
latent
infect
cell
block
lytic
replic
thu
provid
opportun
develop
novel
therapeut
approach
herpesvirus
although
similar
exist
signific
differ
util
host
metabol
resourc
herpesvirus
report
exampl
hcmv
increas
level
tricarboxyl
acid
tca
metabolit
fuell
fatti
acid
synthesi
increas
level
flux
tca
cycl
drive
pyrimidin
synthesi
metabol
z
wang
et
al
virolog
signatur
iltv
yet
address
interestingli
data
demonstr
src
inhibit
promot
intercellular
iltv
spread
host
cellular
fatti
acid
metabolismdepend
manner
fig
src
myristoyl
protein
found
within
outsid
lipid
raft
well
within
endosom
transloc
plasma
membran
seong
et
al
src
activ
exogen
satur
fatti
acid
palmit
myrist
acid
overexpress
cluster
differenti
also
name
fatti
acid
translocas
known
facilit
longchain
fatti
acid
uptak
myristoyl
src
lead
activ
downstream
signal
jnk
signal
holzer
et
al
huang
et
al
kim
et
al
kim
et
al
park
et
al
nonetheless
given
increas
fatti
acid
oxid
observ
mice
knockout
fyn
anoth
src
kinas
famili
member
basti
et
al
src
activ
iltv
infect
may
limit
viral
intercellular
spread
balanc
host
fatti
acid
metabol
negat
src
inhibit
result
acceler
viral
spread
exacerb
cpe
infect
observ
model
hypothesi
partial
support
find
inhibit
src
rescu
reduc
transcript
gene
involv
fatti
acid
metabol
fig
tabl
promot
effect
src
inhibit
intercellular
viral
spread
cytopathogen
iltv
significantli
attenu
modul
host
fatti
acid
synthesi
fig
exclud
potenti
offtarget
effect
src
inhibitor
two
inhibitor
employ
studi
conclus
made
similar
result
obtain
use
inhibitor
gener
lmh
cell
line
chicken
embryo
src
knockout
background
use
system
greatli
help
investig
srcmediat
mechan
iltv
infect
exclud
cell
type
chemic
specif
effect
consid
heterogen
environ
difficulti
associ
control
monitor
celltocel
spread
iltv
vivo
vitro
studi
carri
investig
effect
src
iltv
spread
although
primari
cell
isol
chicken
embryo
better
mimic
vivo
process
iltv
infect
instabl
biolog
characterist
differ
isol
short
lifespan
primari
cell
vitro
cultur
limit
use
cellular
molecular
mechanist
studi
lmh
cell
line
suscept
iltv
infect
vitro
previou
studi
found
cell
line
infect
iltv
suffici
mimic
iltv
ovo
infect
srcmediat
mechan
identifi
lmh
cell
valid
ovo
suggest
lmh
cell
infect
iltv
reliabl
vitro
model
studi
iltv
infect
li
et
al
li
et
al
addit
also
analys
publicli
avail
genomewid
gene
express
data
primari
lung
cell
isol
chicken
embryo
infect
differ
virul
iltv
strain
lee
et
al
reveal
host
src
central
regul
molecular
network
induc
iltv
infect
host
cell
li
et
al
result
support
notion
mechan
identifi
lmh
cell
univers
normal
cell
tissu
rather
cell
linespecif
event
thu
lmh
cell
line
select
mechanist
studi
src
regul
iltv
infect
present
research
investig
use
primari
cultur
tissu
sampl
cell
isol
mucos
epithelium
tracheal
conjunctiv
specimen
infect
multipl
iltv
strain
need
determin
univers
regulatori
mechan
src
iltv
spread
reveal
present
studi
iltv
caus
econom
import
chicken
diseas
despit
extens
administr
live
attenu
vaccin
sinc
midtwentieth
centuri
administr
recombin
vaccin
recent
year
infecti
laryngotrach
outbreak
due
iltv
occur
annual
worldwid
cure
similar
alphaherpesvirus
iltv
establish
latenc
trigemin
ganglia
acut
infect
upper
respiratori
tract
reactiv
virus
latent
infect
occur
frequent
host
immun
compromis
drug
effici
treatment
target
iltv
latent
infect
current
avail
previous
identifi
src
key
host
determin
iltv
infect
howev
therapi
target
src
repress
viral
replic
also
exacerb
patholog
effect
iltv
underli
mechan
side
effect
remain
unknown
present
studi
suggest
host
src
control
celltocel
spread
iltv
cellular
fatti
acid
metabolismdepend
manner
determin
cpe
iltv
given
import
celltocel
spread
iltv
infect
find
provid
new
insight
regard
mechan
iltv
infect
may
also
valuabl
futur
develop
novel
therapeut
strategi
refin
ration
design
effect
vaccin
hl
sl
pw
design
experi
wrote
manuscript
zw
bs
qg
ym
yl
zc
hw
lc
ys
perform
experi
zw
bs
qg
hl
sl
pw
analyz
data
author
review
result
approv
final
version
manuscript
author
declar
conflict
interest
content
articl
